ARTICLE
Received 3 Apr 2013 | Accepted 23 Sep 2013 | Published 24 Oct 2013
Maddalena Castelli1,2, Manila Boca1, Marco Chiaravalli1, Harini Ramalingam3,4, Isaline Rowe1, Gianfranco Distefano1, Thomas Carroll3,4 & Alessandra Boletta1
Several organs, including the lungs and kidneys, are formed by epithelial tubes whose proper morphogenesis ensures correct function. This is best exemplied by the kidney, where defective establishment or maintenance of tubular diameter results in polycystic kidney disease, a common genetic disorder. Most polycystic kidney disease cases result from loss-of-function mutations in the PKD1 gene, encoding Polycystin-1, a large receptor of unknown function. Here we demonstrate that PC-1 has an essential role in the establishment of correct tubular diameter during nephron development. Polycystin-1 associates with Par3 favouring the assembly of a pro-polarizing Par3/aPKC complex and it regulates a programme of cell polarity important for oriented cell migration and for a convergent extension-like process during tubular morphogenesis. Par3 inactivation in the developing kidney results in defective convergent extension and tubular morphogenesis, and in renal cyst formation. Our data dene Polycystin-1 as central to cell polarization and to epithelial tube morphogenesis and homeostasis.
1 Division of Genetics and Cell Biology, Dulbecco Telethon Institute (DTI) at Dibit, San Raffaele Scientic Institute, Via Olgettina, 58, 20132 Milan, Italy. 2 Ph.D. Program in Molecular and Cellular Biology, Vita-Salute San Raffaele University, Via Olgettina, 58, 20132 Milan, Italy. 3 Division of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, NA8 124, Dallas, Texas 75390-9148 USA. 4 Department of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, NA8 124, Dallas, Texas 75390-9148 USA. Correspondence and requests for materials should be addressed to A.B. (email: mailto:[email protected]
Web End [email protected] ).
NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 1
& 2013 Macmillan Publishers Limited. All rights reserved.
DOI: 10.1038/ncomms3658
Polycystin-1 binds Par3/aPKC and controls convergent extension during renal tubular morphogenesis
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658
The kidney develops as a result of interactions between the ureteric bud (UB) and the metanephric mesenchyme (MM)1. The UB invades the MM and undergoes a series
of branchings forming the collecting duct system and ureter of the mature kidney1. The UB also induces a condensation and epithelialization of the MM to form comma and S-shaped bodies. The mechanisms responsible for UB branching and MM condensation have been thoroughly studied over the years with important progress being made1. By contrast, the mechanisms responsible for the subsequent steps of maturation have been the focus of more recent studies, and many outstanding questions remain1. Comma and S-shaped bodies are composed of an immature epithelium with a central lumen, which will undergo a programme of patterning. Both MM- and UB-derived structures undergo a programme of tubular elongation necessary to generate the mature nephron and collecting duct system, respectively2.
Recent important progress has been made in understanding the mechanisms underlying the elongation process, as well as the establishment and maintenance of tubular diameter13. This process is achieved by at least two mechanisms. During embryonic development, both the collecting duct and the proximal tubules decrease in diameter. Although cell division is randomly oriented at these stages, tubular elongation involves a process similar to convergent extension (CE) movements, which are known to cause narrowing and elongation of tissues in several systems1. It was recently shown that epithelial cells
composing the tubules achieve a precise orientation and elongate mediolaterally, in a process resulting in cellular intercalation3,4. This process depends on the planar cell polarity pathway (PCP) and involves the formation and resolution of rosettes, in a process closely resembling CE3. Once this initial phase of morphogenesis is completed (approximately at postnatal day 1 in most collecting ducts in the mouse) and the optimal tubular diameter is reached, further elongation of the tubule is achieved by oriented (proximaldistal) cell division (OCD)4,5, ensuring elongation, while preserving a correct diameter. Defects in the PCP pathway altering one or both of these processes have been proposed to contribute to cystogenesis4,5.
Defective regulation of tubular diameter is associated with autosomal dominant polycystic kidney disease (PKD), one of the most common inherited disorders6. The hallmark of this disease is bilateral renal cyst formation, due to loss-of-function mutations in two genes: PKD1 in 85% of cases or PKD2 in the remaining 15%. Expression of the PKD1 gene is developmentally regulated in the kidneys7, suggesting its possible involvement in normal tubular morphogenesis. PKD1 encodes for Polycystin-1 (PC-1), a large plasma membrane receptor of unknown function, with a very large extracellular amino terminus containing protein protein interaction domains, 11 transmembrane domains and a short intracellular carboxy terminus7. PC-1 has been implicated in a number of biological processes7, but to date its precise function remains to be dened. The role of the Pkd1 gene in
E16.5
E15.5
E13.5
a b
c
40
0
10
20
30
40
30
Pkd1+/+ (WT)
Pkd1[afii9797]C/[afii9797]C (KO)
E16.5 Pkd1+/+
E16.5 Pkd1[afii9797]C/[afii9797]C
20
Percentage of tubules
10
* **
*
Number of cells per tubule
14
8
6 **
*
*
*
* *
**
*
0 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Number of cells per tubule
NS
12
***
10
8
**
6
* * *
*
4
* * * *
8
2
*
* *
* *
*
9
*
0
*
WT
KO
DAPI/DBA
E13.5
WT
KO
E15.5
WT
KO
E16.5
d Pkd1+/+ Pkd1[afii9797]C/[afii9797]C
e
Pkd1+/+
Pkd1[afii9797]C/[afii9797]C
24.0%
8090
8.5%
26.0%
7080
12.2%
16.2%
6070
12.7%
10.8%
5060
9.2%
9.4%
4050
12.9%
7.2%
3040
12.3%
3.8%
2030
10.8%
2.1%
1020
12.5%
E-cadherin
P<0.0001
0.6%
010
8.9%
20
10
0
30 0 10 20 30
Percentage of cells
Figure 1 | Defective tubular narrowing and cellular morphology in Pkd1 mutants. (a) Histogram of the percentage (y axis) of DBA-positive tubules with a given number of cells (x axis) per tubule cross-section at E13.5, E15.5 and E16.5 in wt (top, grey bars) or Pkd1DC/DC (bottom, orange bars) kidneys. The squares and bars on top show the average and the distribution (maximum and minimum numbers), respectively. (b) Graph extrapolated from the data in a. Histograms and bars represent the average and s.e.m. At E13.5, n 183 (wt) and n 182 (KO), and at E15.5 and E16.5, n 200 for both the genotypes,
where n indicates the number of tubules counted. Statistical analysis was carried out by analysis of variance followed by the Bonferroni parameter.
NS, nonsignicant; **Po0.01; ***Po0.001. (c) Representative sections of DBA-positive (red) developing tubules at E16.5 of Pkd1 / or Pkd1DC/DC kidneys. Each cell is labelled with an asterisk and the number of cells per cross-section indicated in the lumen. Scale bar, 20 mm. (d) Confocal images (left panels) and cell outlines (right panels) of frontal sections of E15.5 wt (Pkd1 /) or Pkd1 mutant (Pkd1DC/DC) kidneys stained with an antibody to E-cadherin in DBA-positive sections. Images in the left panels represent sections two frames basal to the aPKC staining, as previously described4. Mediolaterally elongated cells are labelled in white, proximaldistally in black, non-elongated cells in grey. Scale bar, 10 mm. (e) Quantication of the angle of cellular elongation relative to the proximaldistal axis of the tubule for Pkd1 / (left) and Pkd1DC/DC (right). The percentage of cells within each 10 increment is shown. White bars represent cells elongated mediolaterally within a 4090 angle. Cells for wt (n 530) and for mutants (n 575) were counted in a
minimum of six kidneys from three litters. Po0.0001. Statistical analysis was performed using the MannWhitney test.
2 NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658 ARTICLE
mediating OCD in the tubules of newborn kidneys has been recently investigated and led to controversial results8,9, whereas the role of PC-1 in tubular morphogenesis and CE during development was not investigated.
Here we show that PC-1 is essential for a proper establishment of tubular diameter and mediolateral cell orientation during embryonic renal development in the mouse. PC-1 directly associates with Par3 and favours the association of a Par3/ atypical protein kinase C (aPKC) complex in a process likely to be important for oriented cell migration and for renal tubular morphogenesis in the developing kidney. In line with this, we also nd that inactivation of the Pard3 gene in the developing kidneys leads to defective CE and to a non-fully penetrant renal cystic phenotype.
ResultsDefective CE in Pkd1DC/DC kidneys. To test whether PC-1 is involved in CE during renal development, we analysed a Pkd1 mutant allele previously described by our group, which lacks the last two exons of the gene, resulting in a mutant protein lacking the intracellular C-tail (Pkd1DC/DC)10. These mice die betweenE.16.5 and E17.5, and display renal cyst formation starting at E15.5 similar to other PKD mice models. The number of cells per cross-section of DBA (Dolichos biorus agglutinin)-positive renal tubules in wild-type (wt) kidneys decreased over time from E13.5 to E16.5 (Fig. 1a,b), indicating that their diameter decreases (Supplementary Fig. S1). Analysis of Pkd1DC/DC mutants showed no signicant difference from wt at E13.5 (Fig. 1a,b), but a signicant defect in tubular narrowing as compared with the wt
Pkd1+/+
GPS
Pkd1/
Coiled-coil
FL-PC1
NTF
CTF
P100
R4227X-PC1
+ Cre
HA
90
90
90
90
180 180
0 0
LRR PKD REJ TM
50
MEF
Pkd1+/+
Pkd1/
90
MDCK
Pkd1HA/HA
(Pkd1flox/flox)
Percentage of cells
40
180
0
Pkd1/
F2 PKD1
36
Pkd1HA/HA
Pkd1+/+
30
90
+
FL-PC1
NTF
205 kDa 205 kDa
LRR FL-PC1
CTF
-Tubulin
20
10
0 15 30 45 60 75 90 105 120 135 150
165
180
Backward migration
80 *** ***
**
Pkd1+/+
80
***
70
70
Percentageof polarized golgi
40
Randompolarized
Percentageof polarized golgi
40
Pkd1+/+
60
60 NS
50
NS
30
FL-PC1
HA
CTF
-Tubulin
50
205 kDa
30
20
20
10
10
120 kDa
0
0
Pkd1/
Pkd1+/+
Pkd1/
Cre
Cre+
F2
Zeo
F6
36
68
G3
GFP
CTF
FL-PC1
R4227X
CTF
FL-PC1
R4227X
Pkd1HA/HA
(Pkd1flox/flox)
PKD1Zeo
DAPI/-tubulin/MTOC
Figure 2 | PC-1 controls polarized migration. (a) Tracking of cells of Pkd1 / and Pkd1 / MEFs in 12-h wound-healing time-lapse experiments. Each coloured line is a cell. (b) Scheme and quantication of the experiments in a. The angle of deviation a of each trajectory from a theoretical linear migration (equal to angle 0) was calculated. Cells (n 102) from nine movies in three independent experiments per cell line. Statistical analysis was
performed using the MannWhitney test. Po0.0001. (c) Left, Pkd1 / or Pkd1 / MEFs subject to wound healing followed by IF with an anti-a-tubulin (green), anti-pericentrin (red) and DAPI (blue). Scale bar, 20 mm. Right, quantication of frontrear polarity on three independent MDCKPKD1Zeo clones (36, 68 and G3) and two independent MDCKZeo (F2 and F6), on Pkd1/ or Pkd1 / MEFs or Pkd1ox/ox MEFs treated or not with a Cre-recombinase.
The red line shows a theoretical random distribution (33%). Statistical analysis was performed using the Students t-test (for MEFs, left) or analysis of variance (ANOVA; for PKD clones, right) followed by the Bonferroni parameter. **Po0.01; ***Po0.001. Data are meanss.d. and are representative of a minimum of three independent experiments performed in triplicate, in which at least 300 cells were counted. (d) Diagram of PC-1 different isoforms and/or mutant constructs. (e) Immunoblotting of PC-1 in broblasts or in MDCKPKD1Zeo (36) and MDCKZeo (F2) using an anti-LRR antibody (7e12, see
Methods), detects both the full-length (FL-PC-1, B520 kDa) and the cleaved, N-terminal fragment (NTF, B400 kDa). No signal is observed in Pkd1 / cells. (f) Immunoblotting of endogenous tagged PC-1 using an anti-HA detects two bands corresponding to the full-length uncleaved PC-1 (FL-PC-1,
B520 kDa) and the C-terminal fragment (CTF, B150 kDa). Treatment with a Cre-recombinase causes disappearance of FL-PC-1-HA detection. (g) MDCK type-II cells were transiently transfected with green uorescent protein alone or along with full-length PC-1 (FL-PC-1), the R4227X or the CTF HA-tagged mutants. After sorting, cells were treated as in c. Data are meanss.d.; Statistical analysis was performed using ANOVA followed by Bonferroni parameter. ***Po0.001, NS, nonsignicant.
NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 3
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658
tubules at later stages (E15.5 and E16.5, Fig. 1a,b,c and Supplementary Fig. S1). Staining with Ki67, terminal transferase dUTP nick-end labelling (TUNEL) and cleaved caspase-3 revealed that neither differences in proliferation nor in apoptosis could account for the differences between Pkd1 / and
Pkd1DC/DC tubules (Supplementary Fig. S1). Conversely, analysis of the morphology of epithelial cells in DBA-positive tubules revealed that the mediolateral orientation normally observed in wt was lost in Pkd1DC/DC developing kidneys at E15.5 (Fig. 1d,e and Supplementary Fig. S1).
PC-1 regulates the frontrear polarity and oriented migration. We next aimed at investigating the molecular mechanism underlying this defect. Unfortunately, an appropriate functional assay to study CE or planar polarity in vitro is not available. However, the process of CE is intimately linked to the capability of cells to migrate and orient correctly. Therefore, we used cells derived from Pkd1/ or Pkd1 / mice (mouse embryonic broblasts, MEFs), in which we have previously reported a defect in migration rates11. During our assays, we noticed that in
wound-healing assays Pkd1 / MEFs took a contorted path to ll the wound, whereas wt cells migrated in a more linear manner (Fig. 2a,b). Furthermore, Pkd1 / cells failed to relocate their microtubule organizing centre and Golgi in front of their nuclei to generate frontrear polarity as observed in wt cells12,13 (Fig. 2c).
Next, we isolated MEFs derived from a mouse model expressing a oxable haemagglutinin (HA)-tagged endogenous PC-1 (Pkd1HA/HA or Pkd1ox/ox interchangeably)10. As previously described, HA tags were inserted in-frame into the last exon of the Pkd1 gene, resulting in the expression of HA-tagged endogenous PC-1 (ref. 10, Fig. 2f). These lines also carry loxP sites anking exon 45 and exon 46 (ref. 10). Therefore, on treatment with a Cre-recombinase, Pkd1HA/HA generate the Pkd1DC/DC alleles described above, which have lost the proteins C terminus and its detectability (Fig. 2c,f). Importantly, we found that these cells have lost their capability to polarize in wound-healing assays (Fig. 2c).
Furthermore, a set of MadinDarby canine kidney, type-II (MDCK type-II) cells overexpressing PC-1 (ref. 14) acquired a polarized migratory phenotype as compared with controls (Fig. 2c). Finally, transient overexpression of wt FL-PC-1, but
Input IP -HA
aPKC
Par6
Par3
PB1 C1 Kinase domain
PB1 PDZ
WT
HA WT
HA
205 kDa
120 kDa*
o
HA
FL-PC-1 520 kDa
CTF 150 kDa
150 180
CR1
PDZ domains
100
Input
IP -HA
Par3-100 Par3-180 PC1-HA
HA
+
+
+
+
+
+
+
205 kDa
120 kDa*
+ +
-Tubulin
Par3
T410-PKC
PKC (75 kDa)
Par6 (43 kDa)
o
Par3
80
60
40
20
-Tubulin
NS
NS
Percentage of
polarized golgi
GST pull-down
Input
** **
1 2 3
35 kDa 25 kDa
35 kDa 25 kDa
1 2 3 GST-Par3-PDZ
HIS-PC-1-CT
HIS
GST
+
+ + +
0
PKC
WT
KD
WT
KD
36 68
Figure 3 | PC-1 interacts with the Par3/aPKC complex. (a) MEFs isolated from a mouse model carrying HA-tagged endogenous PC-1 (ref. 10) or from littermate embryos (wt) were subject to IP with anti-HA antibodies. Western blotting using anti-HA antibodies revealed the presence of both full-length (arrow, B520 kDa) as well as cleaved C-terminal fragment (CTF; *, B150 kDa) isoforms of endogenous, tagged PC-1. Immunoblot analysis of the same IPs using anti-PKCz and anti-phosphoThr410-PKCz revealed that PKCz (78 kDa) interacts with PC-1 in its active form; analysis using anti-Par3 antibodies reveals that PC-1 also coprecipitated with Par3 (180 kDa (y)) and Par3 (100 kDa ()); analysis using anti-Par6 (43 kDa) antibodies revealed that this molecule is not immunoprecipitated. Blot is representative of multiple independent experiments. (b) Transient transfection of a kinase-dead mutant (KD-PKCz) or a wt form (WT-PKCz) in two MDCKPKD1Zeo clones (68 and 36). Data are meanss.d. Statistical analysis was performed using analysis of variance followed by Bonferroni parameter. **Po0.01. NS, nonsignicant. (c) Schematic representation of the aPKC, Par6 and three different isoforms of
Par3; arrows indicate the described interacting domains. (d) Hek293T cells were transiently transfected with HA-tagged full-length PC-1 (PC-1-HA) along with the 180 and 100 kDa forms of YFP-Par3, followed by IP with anti-HA antibodies. The blot is representative of two independent experiments. (e) GST-tagged versions of each of the three PDZ domains of Par3 were immobilized on G-sepharose beads, and subsequently incubated with HIS-PC-1-CT. Immunoblotting with anti-GST revealed that equal amounts of GSTPDZ domains of Par3 were immobilized on the beads. Anti-HIS showed that PC-1-CT interacts with the rst two PDZ domains, but not with the third.
4 NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658 ARTICLE
not of the patient-derived mutant R4227X (ref. 15) or the C-terminal fragment16, induced frontrear polarity (Fig. 2g,h). Thus, in addition to the previously described capability of PC-1 to regulate cell motility11, here we show that PC-1 also regulates the frontrear cell polarity during migration and both the C- and the N-terminal domains are required for this activity.
PC-1 binds the Par3/aPKC complex. Although the capability of cells to reach appropriate frontrear polarity cannot be considered as an in-vitro assay for CE, the two processes share some molecular factors and mechanisms. One of these is the complex composed of aPKC and the polarity proteins Par3 and Par6, which is very important both for frontrear polarity in mammalian cells and for CE in ies and lower vertebrates13,1720. Therefore, we investigated whether PC-1 could interact or regulate components of the Pars/aPKC complex. To this end,
we used MEFs isolated from Pkd1HA/HA knock-in mice (Fig. 2f)10. Immunoprecipitation (IP) studies revealed that PC-1 coprecipitates with aPKC, a fraction of which reveal phosphorylation in Thr410 (Fig. 3a). In line with this, a kinase-dead mutant of aPKC abrogates the frontrear polarity in MDCKPKD1Zeo cells, suggesting that this kinase is important (Fig. 3b), and, in line with published studies, the same mutant abrogated the frontrear polarity in wt MEFs (Supplementary Fig. S2). Notably, endogenous PC-1 coprecipitated Par3 but not Par6 in Pkd1HA/HA MEFs (Fig. 3a), and in reverse IP studies Par3 coprecipitated PC-1 in Pkd1HA/HA MEFs (Supplementary Fig. S2). To dene the domains involved in the interaction, we overexpressed the full-length HA-tagged PC-1 with the 180 kDa or the 100 kDa form of Par3, lacking the aPKC-binding domain (Fig. 3c), and found that the overexpressed PC-1 coprecipitated both isoforms (Fig. 3d). Furthermore, when the same two constructs were transfected into Pkd1HA/HA MEF lines, we found that
Input IP -PKC
Pkd1+/+
Pkd1/
Pkd1+/+
Pkd1/
Pkd1+/+
Pkd1/
CT
300
Percentage of intensity
Pkd1+/+
Pkd1/
**
250
200
150
100
50
0 Par3/ aPKC
Par6/ aPKC
180 kDa
Par3
100 kDa o
PKC (78 kDa)
**
Par6 (43 kDa)
-Tubulin
Pkd1+/+
Pkd1HA/HA
Pkd1HA/HA
0 0 10 25
Par6
Par6 (43 kDa)
Par3
Par3
g
Pkd1+/+
Par6K19A 10 g
Par6K19A 25 g
DAPI/-tubulin/Par3
Input
Par6 25g
o
-Tubulin
FL-PC1
HA
CTF
520 kDa
150 kDa
Par6(43 kDa)
FL-PC1
HA
CTF
80
NS
Input
PKC (78 kDa)
PKC
Percentage of
polarized golgi
70 60 50 40 30 20 10
0
GFP
Par6
* * *
-Tubulin
*
IP -HA
GFP
Par3
scr-CT
# 1
# 2
# 3
IP -HA
PKC
Figure 4 | PC-1 can inuence the ratio of Par3 versus Par6 bound to aPKC. (a) MEF cells were subject to wound, xed and stained for anti-tubulin (green) and anti-Par3 (red). Scale bars, 20 mm. (b) IP from Pkd1/ or Pkd1 / MEFs using an anti-PKCz antibody followed by immunoblotting with an anti-Par3 (180, 150 and 110 kDa) or anti-Par6 (43 kDa) antibody, in Pkd1 / and Pkd1 / MEFs. CT, cell lysate from Pkd1 / MEFs was incubated in the absence of primary anti-PKC antibody. The blot is representative of seven independent experiments. (c) Quantication of the intensity of bands from seven independent experiments carried out as in b. Data are meanss.e.m. Statistical analysis was performed using analysis of variance (ANOVA) followed by Bonferroni parameter. **Po0.01. (d) Green uorescent protein (GFP)-positive cells, transfected with GFP, Par6 (GFP, bicistronic vector) or Par3 (180 kDa,
YFP-tagged, n 50120), as well as transfected with three Par3 short interfering RNA (number #13, n 600), were analysed for the capability to polarize in
wound-healing assays as in Fig. 2c. Data are meanss.d., and representative of three independent experiments performed in triplicate. Statistical analysis was performed using ANOVA followed by Bonferroni parameter. *Po0.05, NS, non-statistically signicant. (e) Pkd1/ or Pkd1HA/HA MEFs were transfected with increasing amounts of Par6A-expressing constructs, followed by IP with anti-HA beads, followed by western blot analysis with anti-aPKC (78 kDa), anti-Par3 (180 kDa), anti-Par6 (43 kDa) or anti-HA antibodies (full-length PC-1 B520 kDa and C-terminal fragment (CTF) B150 kDa). (f) The experiment was performed as in e, except that the Pkd1HA/HA MEFs were transfected with Par6 or Par6K19A construct (43 kDa), mutated in the aPKC-binding site22.
NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 5
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658
endogenous PC-1 can also interact with both isoforms (Supplementary Fig. S2). Next, we expressed in bacteria the three PDZ domains of Par3, each fused to glutathione S-transferase (GST), and used them in GST pull-down assays along with a histidine-tagged intracellular C-terminal tail of PC-1 (HIS-PC-1-CT)21. We found that HIS-PC-1-CT binds to the rst two PDZ domains of Par3, but not to the third one (Fig. 3e). We conclude that PC-1 C-tail associates directly with Par3 through its rst two PDZ domains. These results along with the capability of PC-1 to interact with Par3 lacking the aPKC-binding domain suggest that probably Par3 mediates the interaction between PC-1 and aPKC.
PC-1 regulates a balance between Par3/aPKC and Par6/aPKC. Next, we looked at the distribution of Par3 in Pkd1 / MEFs subject to wound healing and found that these cells fail to properly localize Par3 in distinct patches aligned along the cell cell contacts, as in wt cells and as previously reported13 (Fig. 4a). Furthermore, IP of aPKC from Pkd1/ and Pkd1 / cells revealed that its association with Par3 is reduced, whereas its association with Par6 is enhanced (Fig. 4b,c). We hypothesized that changes in the ratio of the Par3 or Par6 bound to aPKC might inuence polarized migration. Indeed, overexpression of Par6A was able to displace Par3 from aPKC (Supplementary Fig. S3) and caused an impairment of the frontrear polarity (Fig. 4d). Overexpression of Par3 did not have an effect on
polarity (Fig. 4d), whereas its silencing impaired the frontrear polarity (Fig. 4d and Supplementary Fig. S3). Importantly, over-expression of wt Par6A in Pkd1HA/HA broblasts competes away the association between PC-1 and aPKC in a dose-dependent manner (Fig. 4e). Using a Par6 mutant (Par6K19A), which lacks the capability to bind aPKC22, we found that the interaction between Par6 and aPKC is required for its competing activity (Fig. 4f), suggesting that Par6 subtracts aPKC from PC-1/Par3 by binding directly to aPKC. Thus, PC-1 associates with a Par3/ aPKC complex (which is in competition with a Par6/aPKC complex) to regulate the frontrear polarity.
PC-1 and Par3 associate in vivo. As the Par3/aPKC complex was reported to regulate CE in Drosophila and lower vertebrates20,23,24, we next investigated whether PC-1 interaction with Par3/aPKC could be detected in vivo using our unique murine model of tagged endogenous PC-1 (ref. 10). First, we found that the expression levels and cleavage products of PC-1 in the developing kidney in the time window when CE occurs (E13.5 to P1, Fig. 5ac) are regulated. Notably, the full-length uncleaved PC-1 levels are maximal in the kidney at E13.5 and progressively decrease during development up to birth; although it is visible in longer exposure times (Fig. 5c), the cleaved C-terminal fragment increases progressively and the P100 (ref. 25) only appears in the newborn kidneys (Fig. 5c). Importantly, the expression pattern of
Input
IP -PKC
No. of cells per tubule
12 10
8 6 4 2 0
14
E13.5 E15.5 E16.5
E13.5
P1
Pkd1+/+
Pkd1[afii9797]C/[afii9797]C
Pkd1+/+
Pkd1[afii9797]C/[afii9797]C
DAPI/DBA
CT
E13.5
E15.5
E16.5
P1
#
Par6 (43 kDa)
Par3
-Tubulin
E15.5
E17.5
P1
Input
WT
IP -HA Input
WT
HA
WT
HA
HA
WT
HA
HA
205 kDa
120 kDa
85 kDa
IP -HA
520 kDa 520 kDa
HA
HA
Percentage of intensity
50
250
Pkd1+/+
Pkd1[afii9797]C/[afii9797]C
* **
185 kDa 115 kDa
**
*
#
205 kDa
200
150
100
#
Par3
**
120 kDa
*
Par3
-Tubulin
#
Par3
PKC (78 kDa)
PKC (78 kDa)
P-aPKC
aPKC (78 kDa)
-Tubulin
0 Par6/
Par3/ aPKC
aPKC
PKC (78 kDa)
-Tubulin -Tubulin
Figure 5 | PC-1 interacts with and regulates Par3/aPKC in the developing kidneys. (a) Images of DBA-positive tubules at the stages indicated show narrowing of the tubules. Scale bar, 20 mm. (b) Histogram quantifying the process illustrated in a; graphs are averages.e.m. of the number of cells per tubule cross-section. (c) Western blot analysis on lysates derived from pools of E13.5, E15.5, E17.5 and P1 developing kidneys from Pkd1HA/HA mice, using
anti-HA (top panel), anti-Par3 (middle panel) and anti-phosphorylated (T410), or total levels of aPKC antibodies (bottom panel). Representative western
blotting of three independent experiments. Arrow, full-length PC-1 (B520 kDa); *, C-terminal fragment (CTF) cleavage product of PC-1 (B150 kDa);
**, P100 cleavage product of PC-1 (B100 kDa); y, 180 kDa Par; #, 150 kDa Par3; , 100 kDa Par3. (d) E15.5 total embryo lysates from Pkd1HA/HA (HA) or Pkd1 / (wt) mice were used to immunoprecipitate PC-1 using anti-HA antibodies, followed by immunoblotting with anti-HA (top), anti-Par3 (middle) or anti-PKCz antibodies (bottom). Arrow, full-length PC-1 (B520 kDa); *, CTF cleavage product of PC-1 (B150 kDa); y, 180 kDa Par; #, 150 kDa Par3;
, 100 kDa Par3. (e) PC-1 was immunoprecipitated from kidneys of Pkd1HA/HA or Pkd1 / at E17.5 using anti-HA antibodies, followed by immunoblotting with anti-HA, anti- Par3 and anti-aPKC antibodies. Arrow, full-length PC-1 (B520 kDa); *, CTF cleavage product of PC-1 (B150 kDa); y, 180 kDa Par. (f) IP analysis from E16.5 Pkd1 / or Pkd1DC/DC kidneys using an anti-PKCz antibody followed by immunoblotting with an anti-Par3 or anti-Par6 (43 kDa)
antibody. CT, cell lysate from Pkd1 / embryonic kidneys was incubated in the absence of primary anti-PKC antibody. The blot is representative of three independent experiments. (g) Quantication as meanss.e.m. of the intensity of bands from three independent experiments performed as in f.
Statistical analysis was performed using analysis of variance followed by Bonferroni parameter. **Po0.01.
6 NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658 ARTICLE
Par3, and specically the 180 kDa isoform26, overlaps with that of full-length PC-1. Second, IP of endogenous HA-PC-1 resulted in coprecipitation of Par3 and aPKC in total embryos at E15.5 (Fig. 5d), in the developing kidneys at E17.5 (Fig. 5e and Supplementary Fig. S2) and in P1 newborn kidneys (Supplementary Fig. S2). Finally, we analysed the aPKC complexes and found that IP of aPKC reveals that it preferentially associates with Par3 in Pkd1 / E17.5 kidneys, whereas it preferentially associates with Par6 in E17.5 Pkd1DC/DC mutant kidneys (Fig. 5f,g). These data are in line with the composition of the complexes observed in cells (Fig. 4b,c). As the Pkd1DC/DC mutants lack the intracellular C-tail of PC-1, our studies support the notion that this region is essential for PC-1 proper function during renal tubular morphogenesis.
Defective CE in Par3-mutant kidneys. We next reasoned that if direct interaction between PC-1 and Par3 is essential to mediate correct CE and renal tubular narrowing, we would predict that mice mutant for Par3 display a similar defect than Pkd1 mutants. Homozygous deletion of Par3 results in embryonic lethality before
E12.5, preventing the analysis of renal development27. Thus, we intercrossed a line harbouring a conditional allele for Par3 (ref. 27) with a line carrying a Hoxb7:Cre (conning Cre expression in the UB)28. Staining of anti-Par3 antibodies conrmed that the protein is lost in a high percentage of cells at E15.5 and at P1 (Supplementary Fig. S4). The resulting mice (Hoxb7Cre; Par3ox/ ) displayed a defective number of cells per tubular cross-sections in DBA-positive tubules at E16.5 (Fig. 6a,b).
Importantly, the Par3 mutants displayed a defective mediolateral orientation of epithelial cells (Fig. 6c). A defective number of cells per tubular cross-sections was also observed at P1 (Fig. 6a,b), when a few cysts and tubular dilatations were also observed in four out of ten Hoxb7Cre;Par3ox/ mice (Fig. 6d). Importantly, in
E15.5 DBA-positive tubules, the rates of cell division were not affected in the Par3 mutants, whereas apoptosis was slightly increased (Supplementary Fig. S4). Furthermore, analysis of markers of apico-basal polarity and tight junctions formation revealed no major defects at this level in the epithelia lacking Par3 (Fig. 6e and Supplementary Fig. S4), in line with previously published studies26. We conclude that indeed Par3 is essential for proper CE during renal development in the mouse and that this
50
50
P1
E16.5
40
40
Ctrl
20
20
Hoxb7Cre;Par3flox/+
Hoxb7Cre;Par3flox/
Hoxb7Cre;Par flox/
(mut)
Percentage of tubules
30
30
14
10
10
0 3 4 5 6 7 8 9 10 11 12 13 14
Number of cells per tubule
15 16
Number of cells per tubule
4
12
0
10 ****
8
****
6
2 0
Ctrl
Mut
Ctrl
Mut
E16.5 P1
Par3flox/+
Bcat/aPKC/DBA
Bcad/Lam/CK
Hoxb7Cre;Par3 flox/
WT
8090 7080 6070 5060 4050
Hoxb7Cre;Par3flox/
18.6%19.3%17.6%
14.3%12.6%
8.5%
5.8%
1.9%1.4%
5.6%
7.9%10.4%11.4%
17.6%15.5%10.4%13.7%7.7%
3040 2030 1020
010
P<0.0001
30
20
10
0
0 10
20 30
Percentage of cells
Figure 6 | Defective CE in Par3 mutants. (a) Histograms showing the distribution of the number of cells per cross-section of tubules as in wt (grey bars, n 100) and Hoxb7Cre:Par3ox/ mutant (orange bars, n 100) developing kidneys at E16.5 or P1; n indicates the number of tubules counted. CTRL,
controls are either Hoxb7Cre:Par3ox/ (at P1) or Par3ox/ (at E16.5). (b) Graph extrapolated from the data in a; histograms and bars represent the average and s.e.m. Statistical analysis was performed by analysis of variance (ANOVA) followed by Bonferroni parameter. ****Po0.0001. (c) Quantication of the angle of cellular elongation relative to the proximaldistal axis of the E15.5 tubule for wt or Hoxb7Cre:Par3ox/ (right), as in Fig. 1e.
Four hundred and eighty-three cells for wt and mutants in a minimum of six kidneys from three litters were counted. Po0.0001. Statistical analysis was performed using the MannWhitney test. (d) Haematoxylin and eosin staining of Hoxb7Cre:Par3ox/ and Hoxb7Cre:Par3ox/ mutant kidneys at P1 show tubular dilatation and small cysts in the Par3 mutants. Scale bar, 100 mm. (e) Sections of control (Par3ox/ , left panel) and mutant (Hoxb7Cre;Par3ox/ , right panel) P1 kidneys stained with antibodies to aPKC (red), b-catenin (green) and the collecting duct maker DBA (purple) in the top panel. In the bottom panel, sections were stained with Laminin (red), E-cadherin (green) and the collecting duct marker cytokeratin (blue). No differences were observed in protein localization/polarity between control and mutant collecting ducts. Scale bar, 20 mm.
NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 7
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658
process is independent of Par3 function in apico-basal polarity, but possibly relies on PCP, as recently demonstrated5.
DiscussionIn this study, we have uncovered a critical role for PC-1 in the recently described CE process essential to achieve proper tubular elongation and morphogenesis. In wt developing kidneys, DBA-positive tubules are composed of an average of 13 cells at E13.5 and an average of 7 cells by E16.5. We have shown that in Pkd1 mutant kidneys, DBA-positive tubules fail to undergo this programme of tubular narrowing. Previous studies have shown that the epithelium of the developing nephron divides in a non-oriented manner, but it undergoes mediolateral cellular orientation4. As this is a hallmark of tissues undergoing a programme of CE to achieve elongation and narrowing29,30, this prompted investigators to hypothesize and, subsequently, to demonstrate that the developing nephron is shaped through CE-like movements3,4. Indeed, cellular intercalation appears to be the mechanism that best explains how epithelial tubules can narrow over time. Here we have shown that the epithelium of DBA-positive tubules lacking functional PC-1 fails to orient mediolaterally, suggesting that PC-1 has an essential role in this process. Our study further uncovers a role for PC-1 in regulation of a programme of cell polarity, enabling cells to properly achieve cellular elongation and frontrear asymmetry during migration in wound-healing assays. We have shown that PC-1 interacts with the aPKC/Par3 (180 kDa) complex and probably regulates it to achieve polarized cell migration.
It is interesting to note that PC-1 interacts with both Par3 and aPKC, but not with Par6. Furthermore, the biochemical composition of the aPKC-containing complexes appears to be altered in Pkd1 mutant cells and kidneys. In wt cells, which are able to properly polarize during migration, aPKC preferentially binds to Par3. In contrast, in cells lacking functional PC-1 aPKC appears to preferentially bind to Par6. In addition, overexpression of Par6 is able to compete with Par3 for binding to aPKC and, in line with this, it is able to subtract aPKC from the PC-1/Par3/ aPKC complex. This prompted us to hypothesize that Par6 and Par3 might actually compete for binding aPKC. Our data are in line with previous models proposed mostly based on studies in Drosophila, demonstrating that Bazooka (Par3) and Par6 can associate into distinct complexes with different functional roles31. Furthermore, a recent study has demonstrated that a competitive binding between Crumbs and Par6 can modulate the exclusion of Par3 from the Par6/aPKC complex, providing further support for a ne-tuned regulation of the so-called Par6/Par3/aPKC complex by competitive binding31.
It is noteworthy that Par3 (180 kDa isoform) and PC-1 appear to follow a similar developmental regulation that parallels the timing of tubular morphogenesis described above. The two proteins are associated in vivo in total embryos and in the developing kidney. We hypothesized that this association might be essential for regulating mediolateral cell orientation and CE during renal tubular morphogenesis. The essential role of the Pars/aPKC complex in regulation of CE downstream of the PCP has been demonstrated in Drosophila melanogaster20,24, whereas a single study has implicated their role in lower vertebrates19. Here we have demonstrated that inactivation of Par3 in the UB of the developing kidney results in defective narrowing of the tubular diameter and defective mediolateral orientation of the epithelia composing these tubules. Thus, our data imply, for the rst time, a role of Par3 in CE and tubular morphogenesis in a mammalian system.
Although our studies provide important novel insight in the function of PC-1 and its role in renal development, one important
question that remains unanswered is whether and how defective CE might result in cyst formation. We show that only B40% of the Hoxb7Cre:Par3ox/ mice develop cysts. Thus, defective CE alone might not be sufcient to cause cyst formation and compensatory mechanisms might exist. Similarly, in a previous study, Nishio et al.8 have shown that defective OCD does not initiate cyst formation in the newborn kidney, as mice mutant for Pkhd1 display defective OCD but not cyst formation. It was proposed that a compensatory mechanism of intercalation might prevent cyst formation in these mice. Thus, one possibility is that neither defects in OCD nor in CE alone are sufcient to initiate cyst formation, but they both might contribute.
In summary, in this study we have described a novel role for PC-1 in regulation of a programme of cell polarity, which is important to achieve proper tubular morphogenesis during renal development. Further studies will be required to assess whether this biological function of PC-1 is important for preventing cyst formation and it is relevant for the disease.
Methods
Antibodies and inhibitors. Anti-a-tubulin and anti-ag antibodies were obtained from Sigma (catalogue number 77418-1EA, T5168, T6793 and F1804). Anti phospho-PKCl/z (Thr410/403; catalogue number 9378) was obtained from Cell
Signaling. DAPI (catalogue number sc-3598), anti-PKCz (sc-216/sc-216-G), anti-Par6 (catalogue number sc-14405), anti-PC-1 (catalogue number sc-130554), anti-His (catalogue number sc-8036) and anti-GST (catalogue number sc-495) were obtained from Santa Cruz. Anti-HA from Roche (rat monoclonal catalogue number 13948000). Anti-Par3 was obtained from Millipore (catalogue number 07330, diluted at 1:300 for immunouorescence (IF) and at 1:1,000 for western blot). Anti-E-cadherin was obtained from Invitrogen (catalogue number 131900). Anti-Giantin (catalogue number PRB-114C) and anti-pericentrin (catalogue number PRB-432C) were obtained from Covance. Anti-ezrin was obtained from Millipore (07130, 1:100); anti-occludin from Invitrogen (711500, 1:500); and anti-beta-catenin (C7207, 1:500), anti-laminin (l9393, 1:500) and anti-CK from Sigma (C2562, 1:500). Rhodamine conjugated-DBA was obtained from Vector Laboratories (cat RL-1032). All primary antibodies were diluted according to the manufacturers instructions unless otherwise stated. HRP-conjugated secondary antibodies (GE Healthcare) were diluted at a 1:7,000 and detection was made with an ECL system (Amersham)
Analysis of Pkd1 mutant mice. The Pkd1DC mouse model has been previously generated and carries loxP sites anking the last two exons of the Pkd1 gene (exons 45 and 46)10. Timed pregnant mice were obtained by overnight crossing wt or Pkd1DC/ mice in 100% Bl6/57, and checking for vaginal plugs the next morning.
The presence of a vaginal plug was dened as gestational day E0.5 (embryonic day0.5). All embryos were collected at the dened embryonic stages (between E13.5 and P1 as specied in the legends) and were 50% females and 50% males. The wt and mutant live (based on heart beating) littermate embryos were evaluated from a minimum of three independent litters. All animal care and experimental protocols on the Pkd1 mutants were conducted upon approval of a specic protocol (IACUC-548) by the Institutional Care and Use Ethical Committee at the San Raffaele Scientic Institute. For biochemical studies, we collected and pooled kidneys at day E13.5, 15.5, E17.5 or P1, lysed them with 0.5% triton lysis buffer; IPs were performed as described below for in-vitro studies.
Evaluation of tubular diameter in vivo. For the evaluation of the number of cells/ tubular cross-section, 12 mm sections of E13.5, 15.5, 16.5 or P1 kidneys were stained with the DBA marker and the nuclear marker DAPI. Nuclei of circle-shaped kidney DBA-positive tubules were counted, excluding from analysis the oval-shaped tubules that have values of ovality at the ImageJ software o0.995 (that is, tubules that are not perpendicularly cross-sectioned). We performed two independent experiments for E13.5, E15.5 and E16.5 live (based on heart beating) littermate embryos, counting 100 wt and 100 mutant tubules for each experiment, as well as for P1 wt kidneys. Whenever the phenotype of the embryos was not overt, the analyses were performed in a blinded manner. For the evaluation of circumference and diameter, for round-shaped tubules, a circumference was tracked going through the centre of all the nuclei of the tubular section; the measure of the circumference and of the related Ferets diameter was quantied by ImageJ software.
Evaluation of cellular orientation in vivo. For the evaluation of cell elongation and orientation, E15.5 embryos were xed on in ice-cold methanol, included in 5% low-melting agarose, cut in 100- to 150-mm sections with a vibratome and stained with DBA, anti-E-cadherin, anti-PKCz antibodies and DAPI. Z-stacks of renal
8 NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658 ARTICLE
tubules were captured every 1 mm, using UltraView spinning disk confocal microscope (PerkinElmer) with Volocity software. For the evaluation of medio-lateral orientation, cell shape was tracked using the automated Magnetic Lasso tool (Photoshop), on E-cadherin staining in sections taken two frames below (basal to) PKC staining. Only cells in the image where E-cadherin staining outlined the entire cell were used for calculations (cells on the edges that had discontinuous E-cadherin staining were not measured). For all other cells, the length (longest axis) to width (shortest axis) ratio were calculated. Only cells for which the ratio was 41.2 were considered elongated. Those that have a lower ratio (between 1 and 1.2) are depicted in grey and are not considered elongated. For all the others, the angle between the longest axis of the cell and the longitudinal axis of the tubule were calculated using ImageJ software4.
Apoptosis and proliferation in vivo. To monitor apoptosis, cryostat kidney sections of 12 mm were stained with TUNEL and the process was carried out using the DeadEnd Fluorometric TUNEL System Kit (Promega), according to the manufacturers protocol. Sections were costained for DBA and were used at a dilution of 1/100 (Vector Laboratories). For proliferation, sections were permeabilized in TritonX-100 blocked with PBSBSA 3% and normal goat serum 10% at room temperature for 1 h, incubated overnight with the antibody anti-Ki67 or anti-Phh3 at 4 C, washed and incubated with secondary antibodies (Alexa Fluor-conjugated secondary antibodies from InvitrogenMolecular Probes), and DBA was used at a dilution of 1/100. The ProLong Antifade kit (InvitrogenMolecular Probes) was used for mounting the samples.
Wound-healing assays. MDCK type-II and MEF cells were grown on coverslips as high-density monolayers, wounded using a 200-ml pipette tip and allowed to migrate for 3 h (unless otherwise indicated).
For IF studies, paraformaldehyde or methanol-xed cells were washed, permeabilized in PBS/0.5% Triton X-100 and blocked (PBS, 3% BSA). Primary antibody was applied (all antibodies were diluted to 1:100 in blocking and incubated for 1 h at 37 C) followed by washes and incubation with secondary antibodies (Alexa Fluor-conjugated secondary antibodies from Invitrogen Molecular Probes). The ProLong Antifade kit (InvitrogenMolecular Probes) was used for mounting the samples. Digital images of representative elds were captured using a Zeiss Axiophot uorescence microscope or UltraView spinning disk confocal microscope (PerkinElmer) equipped with a Plan Apochromat 63X/1.4 oil-immersion objective and using the UltraView ERS acquisition software. For time-lapse studies, cells on the wound edge were tracked using the public
domain ImageJ programme (developed at the National Institutes of Health and available at http://rsb.info.nih.gov/ij/
Web End =http://rsb.info.nih.gov/ij/ ). The rate of unidirectional movement was determined following a minimum of ten different cell trajectories from nine movies of three independent experiments (for a total of 102 cells) and measuring the angle formed by the cell trajectories and the perpendicular movement to the wound edge.
Transfection and cell sorting. MDCK cells were transiently transfected using Lipofectamine 2000 (Invitrogen). For IP studies, cells were collected at 4 C in lysis buffer, composed of 150 mM NaCl, 20 mM NaP, 10% glycerol (pH 7.2) supplemented with phosphatase inhibitors (200 mM glycerol phosphate, 200 mM Na orthovanadate and 500 mM Na uoride), protease inhibitor cocktail (Complete, Roche) and Triton X-100 as indicated. and lysed for 30 min on ice. Nuclei were discarded after centrifugation at 13,200 r.p.m. for 10 min. For HA-tagged PC-1 IP, equal amounts of proteins were incubated overnight at 4 C with Anti-HA Afnity Matrix (catalogue number 11815016001, Roche); after washes, immunoprecipitates were run on NuPAGE Novex 38% TrisAcetate Gel (catalogue number EA0375BOX, Invitrogen). For PKCz IP studies, equal amount of proteins were incubated in rocking with the primary anti-PKCz antibody overnight at 4 C, then G-sepharose beads (catalogue number 17-0618-01, GE Healthcare) were added and incubated 2 h at room temperature. IPs were followed by immunoblotting with the indicated primary antibodies (see above). For cell-sorting experiments, parental MDCK type-II cells were transiently transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturers directions by using 12 mg total DNA.
For cell sorting, transfections were performed using a construct expressing green uorescent protein (pEGFP-N1, Clontech) as a marker for cell sorting in combination with PC-1 different constructs (see Fig. 2d). The following day, cells were analysed by FACS Vantage DIVA sorter (Becton Dickinson). Green uorescent protein-positive cells were sorted, replated in 60-mm dishes containing coverslips and after 36 h cells were analysed by western blotting or challenged by wound healing followed by IF to nuclei and Golgi/microtubule organizing centre as described. Full images of western blottings are shown in Supplementary Fig. S5.
IP studies and GST pull-down assays. For immunoblotting, IP study and GST pull-down assay, lysis buffer composed of 150 mM NaCl, 20 mM NaP, 10% glycerol (pH 7.2) supplemented with phosphatase inhibitors (200 mM glycerol phosphate, 200 mM Na orthovanadate and 500 mM Na uoride), protease inhibitor cocktail (Complete, Roche) and Triton X-100 as indicated.
For GST pull-down assays, the indicated GST-fused PDZ domains of Par3 and HIS-fused C-terminus of PC-1 (aa4132-4303) were expressed in Escherichia coli strain BL21. Bacteria were lysed by sonication in 0.1% Triton X-100 lysis buffer and
cleaned by centrifugation. GST-fused protein supernatants were incubated at 4 C with glutathione beads. Beads were centrifuged, washed and incubated with HIS-fused PC-1 supernatants for 3 h at 4 C (1:60 in volume of this supernatant was used in immunoblotting as input). After centrifuging and washing the beads, proteins were solubilized in Laemmli buffer and analysed by immunoblotting. Full images of western blottings are shown in Supplementary Fig. S5.
PAR3 silencing. Control non-targeting short interfering RNA pool (catalogue number D-001206-13-20) and three short interfering RNA targeting Par3 (Par3#1: 50-AGACAGACUGGUAGCAGUAUUUU-30; Par3#2: 50-GUGAAAUUGAGGUC
ACGCCUUUU-30; and Par3#3: 50-GUGAAAUUGAGGUCACGCCUU-30), as well as scramble controls were obtained from Thermo ScienticDharmacon. To transiently silence Par3, we used Lipofectamine (Invitrogen) transfection, following the manufacturers directions.
Par3-mutant generation and analysis. Hoxb7Cre mice27 were bred to mice carrying a mutant allele of Pard3 (ref. 26). Hoxb7Cre;Par3 / males were crossed to females that were homozygous for an allele of Pard3 in which the third coding exon was anked by loxp sites (Par3ox/ox). Noon of the day of vaginal plugging was considered embryonic day 0.5. Litters (half females and half males) were collected at various timepoints for mutant analysis and genotyped by PCR. For Cre-recombinase, the following primers were used: Hoxb7Cre: forward 50-GGT
CAC GTG GTC AGA AGA GG-30; Hoxb7Cre: reverse 50-CTC ATC ACT CGT TGC ATC GA-30. Presence of Hoxb7Cre results in a 400-bp product. For Par3, the following primers were used: 423iF, 50-AGG CTA GCC TGG GTG ATT TGA
GAC C-30; 159iR, 50-TTC CCT GAG GCC TGA CAC TCC AGT C-30; and 382iF, 50-GTC TGT GGG GGT TTT GGG AGA GAG G-30, resulting in products of 371 bp (lox), 292 bp (null) and 265 bp (wt) when resolved on a 3% agarose gel. Mutant embryos (Hoxb7Cre;Par3ox/ ) were compared with littermates either with no Cre (Par3 /ox) or no null allele (Hoxb7cre;Par3ox/ ).
All animals for these studies were housed, maintained and used according to protocols approved by the Institutional Animal Care and Use Committees at the University of Texas Southwestern Medical Center (animal protocol number 1048-06-01-1).
Statistical analysis. Students t-test or one-way analysis of variance was applied to establish differences between means as indicated in the gure legends. Multiple comparisons were carried out using the Bonferroni parameter. Non-parametric MannWhitney test was used for the distribution of the angles of migration (Fig. 2b and Supplementary Fig. S3) and for the distribution of cell orientation in the developing tubules (Figs 1e and 6c).
References
1. Costantini, F. Genetic controls and cellular behaviors in branching morphogenesis of the renal collecting system. WIRE Dev. Biol. 1, 693713 (2012).
2. Costantini, F. & Kopan, R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell 18, 698712 (2010).
3. Lienkamp, S. S. et al. Vertebrate kidney tubules elongate using a planar cell polarity-dependent, rosette-based mechanism of convergent extension. Nat. Genet. 44, 13821387 (2012).
4. Karner, C. M. et al. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat. Genet. 41, 793799 (2009).
5. Fischer, E. et al. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 38, 2123 (2006).
6. Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 12871301 (2007).
7. Boletta, A. & Germino, G. G. Role of polycystins in renal tubulogenesis. Trends Cell Biol. 13, 484492 (2003).
8. Nishio, S. et al. Loss of oriented cell division does not initiate cyst formation.J. Am. Soc. Nephrol. 21, 295302 (2009).9. Luyten, A. et al. Aberrant regulation of planar cell polarity in polycystic kidney disease. J. Am. Soc. Nephrol. 21, 15211532 (2010).
10. Wodarczyk, C. et al. A novel mouse model reveals that polycystin-1 deciency in ependyma and choroid plexus results in dysfunctional cilia and hydrocephalus. PLoS One 4, e7137 (2009).
11. Boca, M. et al. Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell cell mechanical adhesion. Mol. Biol. Cell 18, 40504061 (2007).
12. Etienne-Manneville, S. & Hall, A. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106, 489498 (2001).
13. Schmoranzer, J. et al. Par3 and dynein associate to regulate local microtubule dynamics and centrosome orientation during migration. Curr. Biol. 19, 10651074 (2009).
NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 9
& 2013 Macmillan Publishers Limited. All rights reserved.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3658
14. Boletta, A. et al. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol. Cell 6, 12671273 (2000).
15. Qian, F. et al. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 16, 179183 (1997).
16. Qian, F. et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc. Natl Acad. Sci. USA 99, 1698116986 (2002).
17. Etienne-Manneville, S. & Hall, A. Cell polarity: Par6, aPKC and cytoskeletal crosstalk. Curr. Opin. Cell Biol. 15, 6772 (2003).
18. Pegtel, D. M. et al. The Par-Tiam1 complex controls persistent migration by stabilizing microtubule-dependent front-rear polarity. Curr. Biol. 17, 16231634 (2007).
19. Hyodo-Miura, J. et al. XGAP, an ArfGAP, is required for polarized localization of PAR proteins and cell polarity in Xenopus gastrulation. Dev. Cell 11, 6979 (2006).
20. Simoes Sde, M. et al. Rho-kinase directs Bazooka/Par-3 planar polarity during Drosophila axis elongation. Dev. Cell 19, 377388 (2010).
21. Wodarczyk, C. et al. Nephrocystin-1 forms a complex with polycystin-1 via a polyproline motif/SH3 domain interaction and regulates the apoptotic response in mammals. PLoS One 5, e12719 (2010).
22. Aranda, V. et al. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat. Cell Biol. 8, 12351245 (2006).
23. Zallen, J. A. & Wieschaus, E. Patterned gene expression directs bipolar planar polarity in Drosophila. Dev. Cell 6, 343355 (2004).
24. Harris, T. J. & Peifer, M. aPKC controls microtubule organization to balance adherens junction symmetry and planar polarity during development. Dev. Cell 12, 727738 (2007).
25. Woodward, O. M. et al. Identication of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. PLoS One 5, e12305 (2010).
26. Lin, D. et al. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat. Cell Biol. 2, 540547 (2000).
27. Hirose, T. et al. PAR3 is essential for cyst-mediated epicardial development by establishing apical cortical domains. Development 133, 13891398 (2006).28. Yu, J., Carroll, T. J. & McMahon, A. P. Sonic hedgehog regulates proliferation and differentiation of mesenchymal cells in the mouse metanephric kidney. Development 129, 53015312 (2002).
29. Bertet, C. & Lecuit, T. Planar polarity and short-range polarization in Drosophila embryos. Semin. Cell Dev. Biol. 20, 10061013 (2009).
30. Yen, W. W. et al. PTK7 is essential for polarized cell motility and convergent extension during mouse gastrulation. Development 136, 20392048 (2009).
31. Morais-de-Sa, E., Mirouse, V. & St Johnston, D. aPKC phosphorylation of Bazooka denes the apical/lateral border in Drosophila epithelial cells. Cell 141, 509523 (2010).
Acknowledgements
We are grateful to other members of the lab Boletta, and to L. Feltri, T. Watnick andA. Mondino for help in manuscript structuring/writing; to Dr. T. Pawson for providing Par3 constructs; to T. Hirose for providing the Par3-mutant mice; and to Dr. T. Huber for the Par3 GSTPDZ domains. This work was supported by Telethon-Italy (TCR05007 and GGP12183) to A.B. and by the NIH (1R01DK09505) to T.C. and H.R. A.B. is an Associate Telethon Scientist.
Author contributions
M.C. designed and performed the experiments, interpreted them, wrote the manuscript. M.B. designed and performed the initial in-vitro studies on polarized migration.M.Ch. performed the crossings for the Pkd1 mutants, collected and analysed data. H.R. performed the crossings for Par3 mutants, collected and analysed samples.I.R. performed proliferation and apoptosis studies in vivo in Pkd1 mutants and analysed some of the cross-section number of cells in DBA-positive tubules in a blinded manner. G.D. performed the transfection and sorting experiments and analysed data T.C. supervised the work on Par3 mutants generation and analysis, and critically read the manuscript. A.B. designed the studies, supervised the work and collaborations, and wrote the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications
Web End =http://www.nature.com/ http://www.nature.com/naturecommunications
Web End =naturecommunications
Competing nancial interests: The authors declare no competing nancial interests.
Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions/
Web End =http://npg.nature.com/ http://npg.nature.com/reprintsandpermissions/
Web End =reprintsandpermissions/
How to cite this article: Castelli, M. et al. Polycystin-1 binds Par3/aPKC and controls convergent extension during renal tubular morphogenesis. Nat. Commun. 4:2658doi: 10.1038/ncomms3658 (2013).
10 NATURE COMMUNICATIONS | 4:2658 | DOI: 10.1038/ncomms3658 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
& 2013 Macmillan Publishers Limited. All rights reserved.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Nature Publishing Group Oct 2013
Abstract
Several organs, including the lungs and kidneys, are formed by epithelial tubes whose proper morphogenesis ensures correct function. This is best exemplified by the kidney, where defective establishment or maintenance of tubular diameter results in polycystic kidney disease, a common genetic disorder. Most polycystic kidney disease cases result from loss-of-function mutations in the PKD1 gene, encoding Polycystin-1, a large receptor of unknown function. Here we demonstrate that PC-1 has an essential role in the establishment of correct tubular diameter during nephron development. Polycystin-1 associates with Par3 favouring the assembly of a pro-polarizing Par3/aPKC complex and it regulates a programme of cell polarity important for oriented cell migration and for a convergent extension-like process during tubular morphogenesis. Par3 inactivation in the developing kidney results in defective convergent extension and tubular morphogenesis, and in renal cyst formation. Our data define Polycystin-1 as central to cell polarization and to epithelial tube morphogenesis and homeostasis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer